Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol Isolate for Menstrual-Related Symptoms
NCT05679830Phase 2Completed
- Sponsor
- C³ Cannabinoid Compound Company
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in dysmenorrhea, sponsored by C³ Cannabinoid Compound Company. Started Sep 2020; status: completed.
02
Drugs
cannabidiol
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT05679830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05679830.